PIONIR Trademark

Trademark Overview

On Wednesday, March 27, 2013, a trademark application was filed for PIONIR with the United States Patent and Trademark Office. The USPTO has given the PIONIR trademark a serial number of 85888116. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2017. This trademark is owned by Glaxo Group Limited. The PIONIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, genitourinary, sexual dysfunction, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
pionir

General Information

Serial Number85888116
Word MarkPIONIR
Filing DateWednesday, March 27, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, genitourinary, sexual dysfunction, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "PIONIR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, July 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 17, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016EXTENSION 5 GRANTED
Thursday, December 1, 2016EXTENSION 5 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 16, 2016EXTENSION 4 GRANTED
Tuesday, May 31, 2016EXTENSION 4 FILED
Thursday, July 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2015EXTENSION 3 GRANTED
Thursday, November 19, 2015EXTENSION 3 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 19, 2015TEAS EXTENSION RECEIVED
Thursday, June 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2015EXTENSION 2 GRANTED
Monday, June 1, 2015EXTENSION 2 FILED
Wednesday, June 24, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Saturday, November 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 20, 2014EXTENSION 1 GRANTED
Thursday, November 20, 2014EXTENSION 1 FILED
Thursday, November 20, 2014TEAS EXTENSION RECEIVED
Tuesday, June 10, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 14, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 25, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 20, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 20, 2013ASSIGNED TO LIE
Tuesday, November 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 23, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 22, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 22, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 8, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 8, 2013NON-FINAL ACTION E-MAILED
Saturday, June 8, 2013NON-FINAL ACTION WRITTEN
Monday, June 3, 2013ASSIGNED TO EXAMINER
Tuesday, April 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 30, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

pionir pharmaceutical treatment disorders substances preparations diseases sexual neurological respiratory ophthalmic